Virological and immunological characteristics of HIV treatment failure

被引:21
作者
Kaufmann, D
Muñoz, M
Bleiber, G
Fleury, S
Lotti, B
Martinez, R
Pichler, W
Meylan, P
Telenti, A [1 ]
机构
[1] CHU Vaudois, Div Infect Dis, CH-1011 Lausanne, Switzerland
[2] CHU Vaudois, Inst Microbiol, CH-1011 Lausanne, Switzerland
[3] Univ Bern, Inselspital, Div Allergol, CH-3010 Bern, Switzerland
关键词
MDR-HIV; fitness; immune recovery; infectivity; replication; drug resistance;
D O I
10.1097/00002030-200008180-00012
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Resistance to antiretroviral treatment is prevalent. There is limited knowledge of the determinants of disease evolution in subjects infected with multidrug-resistant HIV (MDR-HIV). Methods: Infectivity, replication, chemokine receptor usage, and env, gag, protease and reverse transcriptase sequence analysis was performed for MDR-HIV isolates from 14 HIV-infected individuals and compared to wild-type HIV isolates from individuals naive to antiretroviral treatment. Expression of CD45RO/RA, Ki67 and interferon-gamma and CD4 proliferative response to various antigens was determined for individuals infected with MDR-HIV and compared to that in individuals with optimal suppression of viral replication. Results: Infectivity and replication are diminished for various MDR-HIV isolates, usually in the context of an increase in CD4 and CD4+CD45RA+ T-cell counts. However, a number of MDR-HIV isolates are associated with high in vivo viraemia and pronounced immunosuppression, and display in vitro levels of infectivity and replication comparable to those of wild-type strains. No specific genetic sequence or chemokine receptor usage predicted the fitness of an MDR isolate. Conclusions: Despite the biological diversity of resistant viruses and the range of host responses observed, our descriptive analysis indicates that viral factors play a role in determining the degree of immune damage observed in the context of MDR-HIV infection. (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:1767 / 1774
页数:8
相关论文
共 21 条
[11]   Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study [J].
Ledergerber, B ;
Egger, M ;
Opravil, M ;
Telenti, A ;
Hirschel, B ;
Battegay, M ;
Vernazza, P ;
Sudre, P ;
Flepp, M ;
Furrer, H ;
Francioli, P ;
Weber, R .
LANCET, 1999, 353 (9156) :863-868
[12]   Resistance-associated loss of viral fitness in human immunodeficiency virus type 1:: Phenotypic analysis of protease and gag coevolution in protease inhibitor-treated patients [J].
Mammano, F ;
Petit, C ;
Clavel, F .
JOURNAL OF VIROLOGY, 1998, 72 (09) :7632-7637
[13]  
MILLER V, 1999, 2 INT WORKSH SALV TH
[14]   Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy [J].
Nijhuis, M ;
Schuurman, R ;
de Jong, D ;
Erickson, J ;
Gustchina, E ;
Albert, J ;
Schipper, P ;
Gulnik, S ;
Boucher, CAB .
AIDS, 1999, 13 (17) :2349-2359
[15]   HIV treatment failure: Testing for HIV resistance in clinical practice [J].
Perrin, L ;
Telenti, A .
SCIENCE, 1998, 280 (5371) :1871-1873
[16]   Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigen [J].
Sachsenberg, N ;
Perelson, AS ;
Yerly, S ;
Schockmel, GA ;
Leduc, D ;
Hirschel, B ;
Perrin, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (08) :1295-1303
[17]   Detection of low HIV-1 RNA levels in plasma [J].
Schockmel, GA ;
Yerly, S ;
Perrin, L .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1997, 14 (02) :179-183
[18]  
STODDART C, 1999, 6 C RETR OPP INF CHI
[19]  
Telenti A., 1999, AIDS REV, V1, P147
[20]   Interruption of reverse transcriptase inhibitors or a switch from reverse transcriptase to protease inhibitors resulted in a fast reappearance of virus strains with a reverse transcriptase inhibitor-sensitive genotype [J].
Verhofstede, C ;
Van Wanzeele, F ;
Van der Gucht, B ;
De Cabooter, N ;
Plum, J .
AIDS, 1999, 13 (18) :2541-2546